Middletown, DE -- (SBWIRE) -- 09/05/2013 -- VipStockReports.com screens the markets looking for Hot Emerging Micro-cap and Small cap stocks that look to Run High. Our team STRONGLY believes the penny stock market can powerfully reward average traders, and we are here to lead the way. Today our focus is on: ARRIS GROUP DL-,01 (NASDAQ:ARRS), Pilgrim's Pride Corporation(NASDAQ:PPC), Keryx Biopharmaceuticals(NASDAQ:KERX), Sequenom, Inc.(NASDAQ:SQNM)
ARRIS GROUP DL-,01 (NASDAQ:ARRS) was a volume gainer of 1.62 million shares and the average volume of the stock remained 1.16 million shares. The stock opened the session at $15.61 and finished at the end of the day at $15.86 and the stock escalated +1.60%.The market capitalization of the stock remained 2.16 billion. The half-yearly trend of the stock remained positive +44.58%. Arris Enterprises, Inc. develops, manufactures, and supplies telephony, data, video, construction, rebuild, and maintenance equipment primarily for cable system operators in the broadband communications industry worldwide. The company operates in three segments: Broadband Communications Systems (BCS); Access, and Media and Communications Systems (MCS).
For How Long ARRS will fight for Profitability? Read This Trend Analysis report
In the preceding trading session, Pilgrim's Pride Corporation (NASDAQ:PPC) exchanged 1.62 million shares and the average volume remained 1.21 million shares. The stock closed the session at $15.80 with the gain of +1.35%. Tracking three months and 6 months trends, the stock was at of +32.33% and +70.81%, respectively. Pilgrim?s Pride Corporation engages in the production, processing, marketing, and distribution of fresh, frozen, and value-added chicken products in the United States, Mexico, and Puerto Rico.
Will PPC Continue To Move Higher? Find Out Here
Keryx Biopharmaceuticals (NASDAQ:KERX) enhanced +2.37% and its closing price was $9.08. The volume of the stock was 1.60 million shares and the average volume remained 1.68 million shares. Yesterday, the stock traded amid the day price range of $8.77 - $9.10. The market capitalization of the stock remained 742.88 million. The beta of the stock remained 3.89. Keryx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of pharmaceutical products for the treatment of renal disease in the United States.
Why Should Investors Buy KERX After The Recent Gain? Just Go Here and Find Out
Sequenom, Inc. (NASDAQ:SQNM) exchanged 1.59 million shares in the previous trading session, and its average trading remained 4.53 million shares. SQNM dropped -0.34% and it closed the trading at $2.97. The market capitalization of the stock remained 342.63 million. YTD trend of the stock was negative -34%. Sequenom, Inc., a life sciences company, provides genetic analysis solutions in the United States and internationally. It operates through two segments, Molecular Diagnostics and Genetic Analysis. The Molecular Diagnostics segment researches, develops.
Has SQNM Found The Bottom and Ready To Move Up? Find Out Here
We screen the markets looking for Hot Emerging Micro-cap and Small cap stocks that look to Run High. Once we find the 'Next Hot Penny Stock' with Monster Upside Potential we immediately Email it to you in our detailed VIP Report so you can Beat Rest of the Crowd!!
Our team STRONGLY believes the penny stock market can powerfully reward average traders, and we are here to lead the way.
VipstockReports.com newsletters and website: The disclaimer is to be read entirely and fully understood before using our website, or joining our newsletter email list. Never invest into a stock discussed on this website or the Vipstockalerts.com newsletter unless you can afford to lose your entire investment. Please consult with a certified financial advisor before making any investment decisions.
VipStockReports.com and any affiliates and information providers make no implied or express warranties on the information provided. Please verify quotes with your financial advisor before making investment decisions. This is not to be construed as a solicitation to buy or sell securities. As with any stock, the featured companies profiled on the VipstockReports.com web site and/or newsletter involve a high degree of volatility and risk, and all investors should know that they may lose a portion of or all of their investment if they decide to purchase any stocks.
Read Full Disclaimer at: http://www.vipstockreports.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)